Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous wound infusion of ropivacaine after pediatric cardiac surgery
2008-008380-94Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Feb 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine in atrial septal defect (ASD) and Ventricular Septal Defect (VSD), sponsored by Helsinki University Hospital. Primary endpoint: Effect on conventional analgesia requirements. Started Feb 2009; status: completed.
02
Drugs
ropivacaine
03
Conditions
atrial septal defect (ASD)Ventricular Septal Defect (VSD)
Beyond the preview
Go deeper on 2008-008380-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008380-94.